ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

Audio Journal of Oncology, February 26th, 2008 Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma MARTIN DREYLING, University Hospital Grosshaden, Munich REFERENCE: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He gave Peter Goodwin his latest data on combination therapy using the antibody, rituximab, and the emerging rôles of other targeted agents.

You can listen to ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma online on Radio and Podcast. Open the player on this page to stream the available audio.

ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma is an episode from Audio Medica News - Medical News Interviews by Audio Medica.

This episode is 00:06:12 long.

This episode was published on Feb 29, 2008.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Audio Medica News - Medical News Interviews when more episodes are available from the podcast feed.